Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Health Trends (NHTC) Gains from Sales and Divestitures (2022 - 2025)

Natural Health Trends' Gains from Sales and Divestitures history spans 6 years, with the latest figure at $28676.0 for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures fell 4.24% year-over-year to $28676.0; the TTM value through Dec 2025 reached $28676.0, down 4.24%, while the annual FY2025 figure was $28676.0, 4.24% down from the prior year.
  • Gains from Sales and Divestitures reached $28676.0 in Q4 2025 per NHTC's latest filing, down from $186320.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $186320.0 in Q4 2023 to a low of $7178.0 in Q1 2025.
  • Average Gains from Sales and Divestitures over 4 years is $60968.7, with a median of $28294.5 recorded in 2022.
  • Peak YoY movement for Gains from Sales and Divestitures: skyrocketed 500.0% in 2024, then crashed 89.21% in 2025.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $31914.0 in 2022, then skyrocketed by 483.82% to $186320.0 in 2023, then crashed by 83.93% to $29946.0 in 2024, then fell by 4.24% to $28676.0 in 2025.
  • Per Business Quant, the three most recent readings for NHTC's Gains from Sales and Divestitures are $28676.0 (Q4 2025), $186320.0 (Q3 2025), and $14356.0 (Q2 2025).